학술논문

Biomarkers and clinical outcomes after tezepelumab cessation: Extended follow-up from the 2-year DESTINATION study
Document Type
Article
Source
In: Annals of Allergy, Asthma and Immunology. (Annals of Allergy, Asthma and Immunology, September 2024, 133(3):310-317.e4)
Subject
Language
English
ISSN
15344436
10811206